Open access · OA
via Europe PMC
Mesenchymal stem cell senescence as a potency brake: causes, consequences, and cures.
Zhou S, Xie Y, Guo Y, Zhang Y, Liu Y.
Frontiers in aging · 2026
Genomic instability
Epigenetic alterations
Loss of proteostasis
Mitochondrial dysfunction
Cellular senescence
Stem-cell exhaustion
Altered intercellular communication
Stem-cell therapy
Human
Review
Abstract
Mesenchymal stem cells (MSCs) are widely investigated for regenerative medicine, tissue repair, immunomodulation, and selected cancer-related applications because of their multilineage differentiation potential, paracrine activity, immunoregulatory properties, and capacity to home to sites of injury. However, the therapeutic potential of MSCs depends not only on their tissue source or surface-marker expression but also on their functional state. MSC senescence(definition) is not a single phenotypic alteration; rather, it reflects the combined effects of persistent DNA damage response activation, disruption of mitochondrial and metabolic homeostasis, remodeling of epigenetic and secretory networks, and loss of proteostasis(definition). Collectively, these changes drive MSCs toward reduced proliferative capacity, dysregulated paracrine signaling, impaired immunomodulatory activity, and diminished tissue-repair potential, thereby compromising cell-product potency and batch-to-batch consistency. This review summarizes the molecular mechanisms underlying MSC senescence, its source-specific functional consequences, and emerging rejuvenation strategies, with an emphasis on MSC quality control, potency assessment, and clinical translation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fragi.2026.1929624
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
S, Z., Y, X., Y, G., Y, Z., & Y., L. (2026). Mesenchymal stem cell senescence as a potency brake: causes, consequences, and cures. <em>Frontiers in aging</em>. https://doi.org/10.3389/fragi.2026.1929624
Vancouver
S Z, Y X, Y G, Y Z, Y. L. Mesenchymal stem cell senescence as a potency brake: causes, consequences, and cures. Frontiers in aging. 2026. doi:10.3389/fragi.2026.1929624.
BibTeX
@article{zhou2026Mesenc,
title = {Mesenchymal stem cell senescence as a potency brake: causes, consequences, and cures.},
author = {Zhou S and Xie Y and Guo Y and Zhang Y and Liu Y.},
journal = {Frontiers in aging},
year = {2026},
doi = {10.3389/fragi.2026.1929624},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of orthopaedic surgery and research 2026
Citation only
Progress in research on the association between mesenchymal stem cell senescence and knee osteoarthritis.
Stem Cells 2006
Citation only
Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
Astana Medical Journal 2026
Open access · OA
Mesenchymal Stem Cells in Regenerative Therapy: Therapeutic Potential and Applications
International Journal of Molecular Medicine 2015
Open access · CC-BY
Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue
Circulation Research 2011
Open access · OA
Mesenchymal Stem Cells: Biology, Pathophysiology, Translational Findings, and Therapeutic Implications for Cardiac Disease
Stem Cells International 2018
Open access · CC-BY